Nu Skin Enterprises, Inc. (NYSE:NUS - Get Free Report) was the target of a significant decline in short interest in February. As of February 15th, there was short interest totalling 2,130,000 shares, a decline of 16.5% from the January 31st total of 2,550,000 shares. Based on an average daily volume of 791,900 shares, the short-interest ratio is currently 2.7 days. Currently, 4.4% of the shares of the stock are short sold.
Analysts Set New Price Targets
NUS has been the subject of several research reports. DA Davidson dropped their price objective on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a "neutral" rating for the company in a research note on Friday, December 20th. StockNews.com raised shares of Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research note on Tuesday, February 25th.
Read Our Latest Analysis on Nu Skin Enterprises
Nu Skin Enterprises Price Performance
NYSE NUS traded down $0.08 during trading hours on Friday, hitting $7.96. 547,281 shares of the company's stock traded hands, compared to its average volume of 794,097. Nu Skin Enterprises has a 52-week low of $5.95 and a 52-week high of $14.04. The company has a market capitalization of $395.65 million, a PE ratio of -2.70 and a beta of 1.06. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.82 and a quick ratio of 1.17. The firm's 50-day moving average is $7.09 and its 200-day moving average is $7.18.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. The company had revenue of $445.55 million during the quarter, compared to analysts' expectations of $441.10 million. Equities analysts forecast that Nu Skin Enterprises will post 1.05 EPS for the current fiscal year.
Nu Skin Enterprises Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, March 5th. Stockholders of record on Monday, February 24th were paid a $0.06 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $0.24 annualized dividend and a dividend yield of 3.02%. Nu Skin Enterprises's dividend payout ratio (DPR) is -8.14%.
Institutional Trading of Nu Skin Enterprises
Several hedge funds have recently made changes to their positions in NUS. Jane Street Group LLC grew its stake in shares of Nu Skin Enterprises by 358.4% in the 3rd quarter. Jane Street Group LLC now owns 924,993 shares of the company's stock valued at $6,817,000 after buying an additional 723,220 shares during the period. Susquehanna International Group LLP grew its stake in shares of Nu Skin Enterprises by 191.9% in the 4th quarter. Susquehanna International Group LLP now owns 702,127 shares of the company's stock valued at $4,838,000 after buying an additional 461,608 shares during the period. Weiss Asset Management LP purchased a new stake in shares of Nu Skin Enterprises in the 3rd quarter valued at approximately $2,727,000. Two Sigma Advisers LP grew its stake in shares of Nu Skin Enterprises by 61.2% in the 4th quarter. Two Sigma Advisers LP now owns 944,000 shares of the company's stock valued at $6,504,000 after buying an additional 358,400 shares during the period. Finally, D. E. Shaw & Co. Inc. grew its stake in shares of Nu Skin Enterprises by 15.5% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 2,251,352 shares of the company's stock valued at $15,512,000 after buying an additional 301,295 shares during the period. Hedge funds and other institutional investors own 82.84% of the company's stock.
Nu Skin Enterprises Company Profile
(
Get Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Further Reading
Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
